PURCON924 - PUFA IMP and Placebo
University of East Aglia · Awarded
- Buyer
- University of East Aglia
- Status
- Awarded
- Country
- United Kingdom
- Region
- England
- Sector
- Manufacturing
- Reference
- FaT-ocds-h6vhtk-029840
- Published
- 2021-04-26
Tender summary
We are looking to contract with a manufacturer who can: • Provide active Omacor capsules of n-3 PUFA (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in 1g capsules in a 1.3:1 ratio in accordance with specified regulations; • Manufacture matched placebo (palm oil and soybean oil) soft-gel capsules in an 8:2 ratio in accordance with specified regulations; • Bottle and label trial medication in accordance with specified regulations; • QP release the active and placebo capsules with a minimum shelf life of 12 months; and • Either, ship final trial medication direct to participants…
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access